Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_provenance.
- NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_assertion description "[The most prevalent biomarkers in pulmonary adenocarcinoma were KRAS mutations (29%), loss of PTEN expression (18%), EGFR mutations (9%), HER2 amplification (5%) and BRAF mutations (3%), while the prevalence of ALK translocations and PIK3CA mutations was extremely low.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_provenance.
- NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_assertion evidence source_evidence_literature NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_provenance.
- NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_assertion SIO_000772 23876834 NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_provenance.
- NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_assertion wasDerivedFrom befree-2016 NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_provenance.
- NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_assertion wasGeneratedBy ECO_0000203 NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_provenance.
- befree-2016 importedOn "2016-02-19" NP1095878.RAcaXB1jTmGKljmXsCfznA4u_fMX04zL2PjG5HkX2pQXg130_provenance.